OPORF
Price
$0.24
Change
-$0.05 (-17.24%)
Updated
Feb 14 closing price
Capitalization
91.39M
YMAB
Price
$8.51
Change
-$0.01 (-0.12%)
Updated
Aug 8, 11:02 AM (EDT)
Capitalization
387.14M
90 days until earnings call
Interact to see
Advertisement

OPORF vs YMAB

Header iconOPORF vs YMAB Comparison
Open Charts OPORF vs YMABBanner chart's image
OPEN ORPHAN
Price$0.24
Change-$0.05 (-17.24%)
Volume$3K
Capitalization91.39M
Y-mAbs Therapeutics
Price$8.51
Change-$0.01 (-0.12%)
Volume$9.49K
Capitalization387.14M
OPORF vs YMAB Comparison Chart in %
Loading...
YMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OPORF vs. YMAB commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OPORF is a Buy and YMAB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (OPORF: $0.24 vs. YMAB: $8.52)
Brand notoriety: OPORF and YMAB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OPORF: 100% vs. YMAB: 163%
Market capitalization -- OPORF: $91.39M vs. YMAB: $387.14M
OPORF [@Biotechnology] is valued at $91.39M. YMAB’s [@Biotechnology] market capitalization is $387.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OPORF’s FA Score shows that 2 FA rating(s) are green whileYMAB’s FA Score has 0 green FA rating(s).

  • OPORF’s FA Score: 2 green, 3 red.
  • YMAB’s FA Score: 0 green, 5 red.
According to our system of comparison, OPORF is a better buy in the long-term than YMAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

YMAB’s TA Score shows that 6 TA indicator(s) are bullish.

  • YMAB’s TA Score: 6 bullish, 4 bearish.

Price Growth

OPORF (@Biotechnology) experienced а 0.00% price change this week, while YMAB (@Biotechnology) price change was +90.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

YMAB is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
YMAB($387M) has a higher market cap than OPORF($91.4M). YMAB YTD gains are higher at: 8.812 vs. OPORF (-34.871). OPORF has higher annual earnings (EBITDA): 14M vs. YMAB (-30.39M). YMAB has higher revenues than OPORF: YMAB (88.7M) vs OPORF (56M).
OPORFYMABOPORF / YMAB
Capitalization91.4M387M24%
EBITDA14M-30.39M-46%
Gain YTD-34.8718.812-396%
P/E Ratio11.75N/A-
Revenue56M88.7M63%
Total CashN/A60.3M-
Total DebtN/A603K-
FUNDAMENTALS RATINGS
YMAB: Fundamental Ratings
YMAB
OUTLOOK RATING
1..100
31
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OPORFYMAB
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
77%
Stochastic
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
14%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
14%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
N/A
Bullish Trend 11 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 22 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
YMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCKHF1.070.04
+3.76%
Rockhopper Exploration Plc
EGFEF3.86N/A
N/A
EUROBANK ERGASIAS SVCS AND HOLDINGS SA
HUBV0.11N/A
N/A
Hubb Ventures Inc.
BAIDF10.86N/A
N/A
Baidu, Inc.
OERLF4.13-0.40
-8.83%
OC Oerlikon Corp.

OPORF and

Correlation & Price change

A.I.dvisor indicates that over the last year, OPORF has been loosely correlated with YMAB. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if OPORF jumps, then YMAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPORF
1D Price
Change %
OPORF100%
N/A
YMAB - OPORF
34%
Loosely correlated
N/A
ENTX - OPORF
31%
Poorly correlated
-9.09%
PMN - OPORF
23%
Poorly correlated
-6.76%
EWTX - OPORF
6%
Poorly correlated
-4.18%
BCTX - OPORF
4%
Poorly correlated
+8.49%
More

YMAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, YMAB has been loosely correlated with SNDX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if YMAB jumps, then SNDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To YMAB
1D Price
Change %
YMAB100%
N/A
SNDX - YMAB
45%
Loosely correlated
-1.32%
IDYA - YMAB
45%
Loosely correlated
-5.16%
RXRX - YMAB
44%
Loosely correlated
-1.28%
NUVB - YMAB
44%
Loosely correlated
-0.43%
AURA - YMAB
41%
Loosely correlated
-1.21%
More